Health CanadaGeneral Alert
HepaGam B [Hepatitis B Immune Globulin (Human) Injection] - Theoretical Risk of ...
Published: June 14, 2012Recall ID: 25656Category: generalCountry: Canada
Product Description & Identification
HepaGam B [Hepatitis B Immune Globulin (Human) Injection] - Theoretical Risk of Thrombotic Events with Intravenous Administration and Related Labeling Update - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25656 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/hepagam-b-hepatitis-b-immune-globulin-human-injection-theoretical-risk-thrombotic-0 |
| Title | HepaGam B [Hepatitis B Immune Globulin (Human) Injection] - Theoretical Risk of Thrombotic Events with Intravenous Administration and Related Labeling Update - Notice to Hospitals |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2012-06-14 |
| Organization | Marketed health products |